J
2024
Association of BMI, lipid-lowering medication, and age with prevalence of type 2 diabetes in adults with heterozygous familial hypercholesterolaemia: a worldwide cross-sectional study
ELSHORBAGY, Amany; Alexander R M LYONS; Antonio J VALLEJO-VAZ; Christophe A T STEVENS; Kanika I DHARMAYAT et. al.
Základní údaje
Originální název
Association of BMI, lipid-lowering medication, and age with prevalence of type 2 diabetes in adults with heterozygous familial hypercholesterolaemia: a worldwide cross-sectional study
Autoři
ELSHORBAGY, Amany; Alexander R M LYONS; Antonio J VALLEJO-VAZ; Christophe A T STEVENS; Kanika I DHARMAYAT; Julia BRANDTS; Alberico L CATAPANO; Tomáš FREIBERGER; G Kees HOVINGH; Pedro MATA; Frederick J RAAL; Raul D SANTOS; Handrean SORAN; Gerald F WATTS; Marianne ABIFADEL; Carlos A AGUILAR-SALINAS; Khalid F ALHABIB; Mutaz ALKHNIFSAWI; Wael ALMAHMEED; Fahad ALNOURI; Rodrigo ALONSO; Khalid AL-RASADI; Ahmad AL-SARRAF; Tester F ASHAVAID; Maciej BANACH; Christoph J BINDER; Mafalda BOURBON; Liam R BRUNHAM; Krzysztof CHLEBUS; Pablo CORRAL; Diogo CRUZ; Kairat DAVLETOV; Olivier S DESCAMPS; Marat EZHOV; Dan GAITA; Urh GROSELJ; Mariko HARADA-SHIBA; Kirsten B HOLVEN; Meral KAYIKCIOGLU; Weerapan KHOVIDHUNKIT; Katarina LALIC; Gustavs LATKOVSKIS; Ulrich LAUFS; Evangelos LIBEROPOULOS; Marcos M LIMA-MARTINEZ; Jie LIN; Vincent MAHER; A David MARAIS; Winfried MARZ; Erkin MIRRAKHIMOV; Andre R MISEREZ; Olena MITCHENKO; Hapizah NAWAWI; Borge G NORDESTGAARD; Andrie G PANAYIOTOU; Gyorgy PARAGH; Zaneta PETRULIONIENE; Belma POJSKIC; Arman POSTADZHIYAN; Ashraf REDA; Zeljko REINER; Ximena REYES; Fouzia SADIQ; Wilson E SADOH; Heribert SCHUNKERT; Aleksandr B SHEK; Erik STROES; Ta-Chen SU; Tavintharan SUBRAMANIAM; Andrey V SUSEKOV; Myra TILNEY; Brian TOMLINSON; Truong THANH-HUONG; Alexandros D TSELEPIS; Anne TYBJAERG-HANSEN; Alejandra C VAZQUEZ; Margus VIIGIMAA; Branislav VOHNOUT; Luya WANG; Shizuya YAMASHITA; Marcello ARCA; Maurizio AVERNA a Kausik K RAY
Vydání
ENDOCRINOLOGY, NEW YORK, ELSEVIER SCIENCE INC, 2024, 2213-8587
Další údaje
Typ výsledku
Článek v odborném periodiku
Stát vydavatele
Spojené státy
Utajení
není předmětem státního či obchodního tajemství
Organizace
Lékařská fakulta – Masarykova univerzita – Repozitář
EID Scopus
2-s2.0-85207124416
Klíčová slova anglicky
BMI; lipid-lowering medication; age; type 2 diabetes; heterozygous familial hypercholesterolaemia
Návaznosti
LX22NPO5104, projekt VaV.
V originále
Background Statins are the cornerstone treatment for patients with heterozygous familial hypercholesterolaemia but research suggests it could increase the risk of type 2 diabetes in the general population. A low prevalence of type 2 diabetes was reported in some familial hypercholesterolaemia cohorts, raising the question of whether these patients are protected against type 2 diabetes. Obesity is a well known risk factor for the development of type 2 diabetes. We aimed to investigate the associations of known key determinants of type 2 diabetes with its prevalence in people with heterozygous familial hypercholesterolaemia.
Zobrazeno: 10. 8. 2025 06:38